| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.29 | 3e-08 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-08 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.24 | 8e-07 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |